EFFECTOR THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EFTR and buy or sell other stocks, ETFs, and their options commission-free!About EFTR
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).
CEOStephen T. Worland
CEOStephen T. Worland
Employees15
Employees15
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded2012
Founded2012
Employees15
Employees15
EFTR Key Statistics
Market cap38.77K
Market cap38.77K
Price-Earnings ratio-12.57
Price-Earnings ratio-12.57
Dividend yield—
Dividend yield—
Average volume2.96M
Average volume2.96M
High today$0.0006
High today$0.0006
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume10.04K
Volume10.04K
52 Week high$1.48
52 Week high$1.48
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
The current EFFECTOR THERAPEUTICS(EFTR) stock price is $0.00, with a market capitalization of 38.77K. The stock trades at a price-to-earnings (P/E) ratio of -12.57.
As of 2026-07-15, EFFECTOR THERAPEUTICS(EFTR) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock +200.0% above today's low and 0.0% off the high.
The EFFECTOR THERAPEUTICS(EFTR)'s current trading volume is 10.04K, compared to an average daily volume of 2.96M.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.00 at its lowest and $1.48 at its peak.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.00 at its lowest and $1.48 at its peak.
People also own
Based on the portfolios of people who own EFTR. This list is generated using Robinhood data, and it’s not a recommendation.